High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study

NCT ID: NCT04025385

Last Updated: 2021-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-30

Study Completion Date

2021-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study with Patients (40-60 participants) above the age of 65. There will be a comparison of regular training on ergometer (10 trainings within 2 weeks, 40 min each) to high intensity interval training on ergometer (6 trainings within 2 weeks, 25 min each). At the beginning and at the end will be a spiroergometer to measure the individual limits and vO2max, which will be compared amongst the two groups. To receive a subjective feedback, there will be a series of questionnaires at the beginning, after one week and at the end. The goal of this study is to get more information about whether a HII-Training is feasible with elderly patients and whether they can profit form it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rehabilitation Post-Operative Condition Deconditioning After Acute Hospital Oncology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Patients will participate in regular training units

Group Type NO_INTERVENTION

No interventions assigned to this group

HIIT Group

Patients will participate in high intensity interval training

Group Type ACTIVE_COMPARATOR

High Intensity Interval Training

Intervention Type OTHER

Training for 25 min with four 1 minute intervals when participants exercise up to 80% of their individual limits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Intensity Interval Training

Training for 25 min with four 1 minute intervals when participants exercise up to 80% of their individual limits.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cardiopulmonal resilient
* able to sit on a ergometer
* knowledge of German written and spoken

Exclusion Criteria

* Severe cardiopulmonary restriction (LVEF \<30%, conduction abnormalities from AV block IIb or higher)
* Absolute cardiopulmonary contraindications (acute coronary syndrome, unstable AP -\> not capable of rehabilitation), uncompensated heart failure (dyspnea at rest, orthopnea, severe edema)
* No ischemic events (cardiac, cerebral, peripheral) within the last 3 months
* Severe pneumatological underlying disease: COPD GOLD 3 and higher or status after exacerbation within the last 2 weeks, Asthma grade 4
* Dyalisis reliant
* Severe psychiatric disorder (severe psychosis, severe depression)
* Distinct dementia
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Klinik Valens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Kruesi

Resident Physician, Doctoral Candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rehazentrum Walenstadtberg

Walenstadtberg, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KLV-BA-2019-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.